// App-Quantinova.ai

4020 : Cardio-Vascular Events Occurring On Ponatinib In Chronic Phase Chronic Myeloid Leukemia Patients, Preliminary Analysis Of a Multicenter Cohort

Researchers

Presenter

  • Franck E. Nicolini

Principal Investigators

  • Marie-Claude Gagnieu

  • Mael Heiblig

  • Mohamad Sobh

  • Gaelle Richard-Colmant

  • Celine Fettig

  • Mauricette Michallet

  • Delphine Rea

  • Emilie Blond

  • Laurence Legros

  • Yann Guillermin

  • Stephane Morisset

  • Fiorenza Barraco

  • Madeleine Etienne

  • Oriane Le Borgne

  • Jeremy Ruby

Medical Centers

  • Centre Hospitalier Lyon-Sud, Pierre-Benite, France

  • Centre de Recherche en Cancerologie de Lyon, Lyon, France

  • Hematologie Adultes, Hopital Saint-Louis, Paris, France

  • Hematology department 1G, Centre Hospitalier Lyon Sud, Pierre Benite, France

  • French group of CML Fi-LMC, Poitiers, France

  • Centre Hospitalier Lyon-Sud, Pierre-Benite, France

  • Centre Hospitalier Lyon-Sud, Pierre-Benite, France

  • Hematology department, Hopital de lArchet, Nice, France

  • Laboratoire de pharmacologie, Hopital Edouard Herriot, Lyon, France

  • Laboratoire de biochimie, Centre Hospitalier Lyon Sud, Pierre Benite, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Chronic Myelogenous Leukemia

  • Myocardial infarction

  • Cystathionine beta-synthase deficiency

  • Hypertension

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 206

  • Vascular endothelial growth factor A

  • Body mass index

Drug/Treatment

  • Nilotinib

  • Ponatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved